Market Overview

Morgan Stanley: Despite Finisar's Weak Q4 Report, Outlook Remains 'Positive'

Share:
Morgan Stanley: Despite Finisar's Weak Q4 Report, Outlook Remains 'Positive'
Related FNSR
Potential Winners And Losers In The Optical Space From The Tariff Dispute
PreMarket Prep Recap For July 5: Trading The Range In The S&P 500; Sean Udall Joins The Show

Optoelectronics company Finisar Corporation (NASDAQ: FNSR) reported Thursday afternoon with disappointing fiscal fourth-quarter results, but that shouldn't alter the bullish long-term thesis, according to Morgan Stanley.

The Analyst

Morgan Stanley's Meta Marshall maintains an Overweight rating on Finisar's stock with an unchanged $20 price target.

The Thesis

Finisar's earnings report was weak across multiple metrics, including a 300-basis point gross margin miss, but this has no bearing on the favorable long-term outlook, Marshall said in a research report. (See the analyst's track record here.) 

Gross margins were impacted by a non-cash inventory reserve in the quarter, while the datacomm market remains weak in China, Marshall said. Finisar's long-term plan suggests a 32-33-percent gross margin rate, and this may be achievable based the following expectations, the analyst said:

  • Progress in the Sherman facility.
  • Lower-cost datacomm products.
  • A return of "some revenue growth" from China.

Finisar's ongoing strategic review process wasn't highlighted by management during the post-earnings conference call, Marshall said. Enough evidence exists to suggest a business review would "take shape in the form" of 12-15-percent operating margin targets through a portfolio review and operating expenditure rationalization, the analyst said. 

The report also shows "early signs" of opex declining toward management's 18-20-percent target, and the company should provide new updates in the near-term that would serve as a driver for the stock in the first half of fiscal 2019, according to Morgan Stanley. 

Price Action

Finisar shares were rallying 4.33 percent to $18.47 at the time of publication Friday. 

Related Links:

Opticals Taking Back Lost Market Share, According To Rosenblatt

Commerce Secretary Wilbur Ross Confirms ZTE Deal

Latest Ratings for FNSR

DateFirmActionFromTo
Apr 2018Morgan StanleyUpgradesEqual-WeightOverweight
Mar 2018Stifel NicolausMaintainsBuyBuy
Mar 2018NeedhamDowngradesBuyHold

View More Analyst Ratings for FNSR
View the Latest Analyst Ratings

Posted-In: China DatacommAnalyst Color Earnings News Price Target Reiteration Analyst Ratings Best of Benzinga

 

Related Articles (FNSR)

View Comments and Join the Discussion!

Global Blood Therapeutics Shares Plunge After Sickle Cell Candidate Shows Reduced Effect

A New ETF Gets Tactical With Growth Stocks